OXTRA DD 100 mg/ml solution for injection for cattle, sheep, pigs, horses, dogs and cats
OXTRA DD 100 mg/ml solution for injection for cattle, sheep, pigs, horses, dogs and cats
Authorised
- Oxytetracycline hydrochloride
Product identification
Medicine name:
OXTRA DD 100 mg/ml solution for injection for cattle, sheep, pigs, horses, dogs and cats
Oxtra DD 100 mg/ml injektionsvæske, opløsning
Active substance:
- Oxytetracycline hydrochloride
Target species:
-
Cattle
-
Dog
-
Sheep
-
Horse
-
Cat
-
Pig
Route of administration:
-
Intramuscular use
-
Intravenous use
-
Subcutaneous use
Product details
Active substance and strength:
-
Oxytetracycline hydrochloride107.93milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal35day24 hour dosage regimen
-
Meat and offal35dayProlonged action dosage regimen
-
Milk72hour24 hour dosage regimen
-
-
Dog
-
Sheep
-
Meat and offal53day24 hour dosage regimen
-
Meat and offal18dayProlonged action dosage regimen
-
Milk120hour24 hour dosage regimen
-
-
Horse
-
Meat and offal6month24 hour dosage regimen
-
-
Cat
-
Pig
-
Meat and offal14day24 hour dosage regimen
-
Meat and offal13dayProlonged action dosage regimen
-
-
-
Intravenous use
-
Cattle
-
Meat and offal35day24 hour dosage regimen
-
Milk72hour24 hour dosage regimen
-
-
Sheep
-
Meat and offal53day24 hour dosage regimen
-
Milk120hour24 hour dosage regimen
-
-
Horse
-
Meat and offal6month24 hour dosage regimen
-
-
Pig
-
Meat and offal14day24 hour dosage regimen
-
-
-
Subcutaneous use
-
Dog
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01AA06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Denmark
Package description:
- 20 ml amber type II glass vial closed with chlorobutyl rubber stopper type I and sealed with an aluminium collar with a tamper-evident polypropylene seal, in a cardboard box.Pack-size:1 x 20 ml glass vial
- 50 ml amber type II glass vial closed with chlorobutyl rubber stopper type I and sealed with an aluminium collar with a tamper-evident polypropylene seal, in a cardboard box.Pack-size:1 x 50 ml glass vial
- 100 ml amber type II glass vial, closed with chlorobutyl rubber stopper type I and sealed with an aluminium collar with a tamper-evident polypropylene seal, in a cardboard box.Pack-size:1 x 100 ml glass vial
- 250 ml amber type II glass vial ,closed with chlorobutyl rubber stopper type I and sealed with an aluminium collar with a tamper-evident polypropylene seal, in a cardboard box.Pack-size:1 x 250 ml glass vial
- 100 ml amber type II glass vials, closed with chlorobutyl rubber stopper type I and sealed with an aluminium collar with a tamper-evident polypropylene seal, in a cardboard box.Pack-size:10 x 100 ml glass vial
- 100 ml amber PET vial, closed with chlorobutyl rubber stopper type I and sealed with an aluminium collar with a tamper-evident polypropylene seal, in a cardboard box.Pack-size:1 x 100 ml PET vial
- 250 ml amber PET vial, closed with chlorobutyl rubber stopper type I and sealed with an aluminium collar with a tamper-evident polypropylene seal, in a cardboard box.Pack-size:1 x 250 ml PET vial
- 100 ml amber PET vials, closed with chlorobutyl rubber stopper type I and sealed with an aluminium collar with a tamper-evident polypropylene seal, in a cardboard box.Pack-size:10 x 100 ml PET vial
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Fatro S.p.A.
Responsible authority:
- Danish Medicines Agency
Authorisation number:
- 62786
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0521/001
Concerned member states:
-
Austria
-
Belgium
-
Denmark
-
Germany
-
Greece
-
Italy
-
Netherlands
-
Poland
-
Portugal
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024
Danish (PDF)
Published on: 4/05/2022
How useful was this page?: